Impact of Alcohol Labels in a Real-World Setting
Launched by WORLD HEALTH ORGANIZATION · Apr 1, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of health labels on alcohol can influence people's knowledge and behavior regarding drinking. Specifically, researchers want to find out if a label warning about the risk of cancer has a stronger effect on people's understanding and attitudes towards alcohol compared to a label that promotes responsible drinking. They will also look into whether placing the label on the front or back of the bottle makes a difference in how people respond.
To participate in this study, you need to be at least 18 years old, have just bought alcohol for personal use, and be able to speak Spanish or Catalan. If you join, you will fill out a short questionnaire, receive a sticker with a health message to place on your alcohol purchase, and then answer two follow-up surveys—one week and one month later. This trial aims to provide valuable insights that could help improve public health messages about alcohol consumption.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • have just purchased at least one alcoholic beverage container for their own consumption
- • speak Spanish or Catalan
- • are 18 years or older
- • provide informed consent to participation
- Exclusion Criteria:
- • - all the purchased alcohol containers are too small for a label sticker to be affixed
About World Health Organization
The World Health Organization (WHO) is a specialized agency of the United Nations dedicated to promoting global health and well-being. As a leading authority in public health, WHO conducts and sponsors clinical trials to advance medical knowledge, develop effective health interventions, and address pressing health challenges worldwide. With a commitment to evidence-based research, WHO collaborates with international partners, governments, and health organizations to ensure that clinical trials adhere to rigorous ethical standards and contribute to the improvement of health outcomes, particularly in underserved populations. Through its extensive network and expertise, WHO plays a pivotal role in shaping health policies and practices on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Daša Kokole, PhD
Principal Investigator
World Health Organisation Regional Office for Europe
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported